CODVIP slot real money
wild tornado World’s first lung cancer vaccine begins human trials
A 67-year-old patient at the University College London Hospital is the first to receive the first-ever lung cancer vaccine.
German biotech firm BioNTech developed this mRNA-based inoculation called BNT116. The vaccine works by activating the immune system so that it recognizes and combats cancer cells.
READ: AMICA maps human immune system with AI
Article continues after this advertisementThe researchers have started the initial trial to adjust the safety of BNT116 and determine its potential side effects.
FEATURED STORIES TECHNOLOGY vivo launches V40 Lite with 5000mAh battery covered by 50-month warranty, starts at Php 13,999 TECHNOLOGY Galaxy Buds3 Pro: Delivering tailored sound wherever you go TECHNOLOGY Very mindful, very intuitive: ASUS’ most superior AI PC yet, the Zenbook S 14, empowers you to achieve more How does the lung cancer vaccine work?A novel cancer vaccine to treat non-small cell lung cancer is being tested for the first time in a patient at University College London Hospitals in the UK. https://t.co/iROPHRZUGO
— ABC Action News (@abcactionnews) August 26, 2024The official UCLH website shares more details regarding the lung cancer vaccine. BNT116 uses a messenger RNA (mRNA) to present non-small cell lung cancer (NSCLC) to the patient’s immune system.
Consequently, the immune system can recognize and fight lung cancer cells. The vaccine also enhances immune responses to reduce the risk of toxicity, making it safer than chemotherapy.
Article continues after this advertisementSixty-seven-year-old Londoner Janusz Racz is one of the 130 who will receive the vaccine in the initial trial. It will span 34 research sites in seven countries, with six in the United Kingdom.
Article continues after this advertisementInteresting Engineering says these nations include the US, Germany, Poland, Hungary, Spain, and Turkey. Also, patients will receive six consecutive injections of the drug, five minutes after the previous one.
Article continues after this advertisement“Dr. Sarah [Benafif] explained how the vaccine should work and how it was different from the treatment I had recently completed,” Racz stated.
“I thought it over and decided to take part because I hoped it would provide a defense against cancer cells,” the patient added.
Article continues after this advertisementUCLH consultant medical oncologist and head of the study Dr. Sarah Benafif explained, “The strength of the approach we are taking is that the treatment is aimed at being highly targeted towards cancer cells.”
“In this way, we hope that in time, we are able to show that the treatment is effective against lung cancer whilst leaving other tissues untouched.”
Subscribe to our daily newsletter
NHS England national cancer director Dame Cally Palmer said: “The NHS has a leading role globally in trialing cancer vaccines and if we are successfulwild tornado, they could be revolutionary in vaccinating people against their own cancers to prevent the cancer recurring after their initial treatment.”
TOPICS: Cancer, technology READ NEXT Last call for students: Get up to 50% off on select HONOR devi... Gogolook to strengthen TrustTech in PH EDITORS' PICK VP Sara Duterte says she still sees Sen. Marcos as a 'friend' Sandro Marcos calls out VP Sara Duterte: ‘You crossed the line’ Party-list system: What to know ahead of 2025 polls WPS: US missile deployment to PH key for combat readiness – US general INQside Look with senatorial aspirant Tito Sotto Espenido retracts drug-related allegations vs De Lima MOST READ SC issues TRO vs Comelec resolution on dismissed public officials Tropical Storm Kristine slightly intensifies; Signal No. 2 in 5 areas Walang Pasok: Class suspensions on Wednesday, Oct. 23 LIVE UPDATES: Tropical Storm Kristine View comments